KR101548694B1 - New pyrimidine derivative and organic light-emitting devices including the same - Google Patents

New pyrimidine derivative and organic light-emitting devices including the same Download PDF

Info

Publication number
KR101548694B1
KR101548694B1 KR1020130036327A KR20130036327A KR101548694B1 KR 101548694 B1 KR101548694 B1 KR 101548694B1 KR 1020130036327 A KR1020130036327 A KR 1020130036327A KR 20130036327 A KR20130036327 A KR 20130036327A KR 101548694 B1 KR101548694 B1 KR 101548694B1
Authority
KR
South Korea
Prior art keywords
compound
aryl
light emitting
heteroaryl
mmol
Prior art date
Application number
KR1020130036327A
Other languages
Korean (ko)
Other versions
KR20140120975A (en
Inventor
박상미
이대희
남현국
이상연
함주석
장승희
조규오
Original Assignee
주식회사 알파켐
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 알파켐 filed Critical 주식회사 알파켐
Priority to KR1020130036327A priority Critical patent/KR101548694B1/en
Publication of KR20140120975A publication Critical patent/KR20140120975A/en
Application granted granted Critical
Publication of KR101548694B1 publication Critical patent/KR101548694B1/en

Links

Images

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/622Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

본 발명은 신규한 피리미딘 유도체 및 이를 발광층에 포함하는 유기 발광 소자에 관한 것으로서, 본 발명에 따른 유기 발광 소자는 발광특성이 뛰어날 뿐만 아니라 구동전압을 강화시켜줌으로써 전력효율의 상승을 유도하여 소비전력이 개선되는 장점을 가진다.The present invention relates to a novel pyrimidine derivative and an organic light emitting device including the same in a light emitting layer. The organic light emitting device according to the present invention not only excels in luminescence characteristics but also enhances a driving voltage, Has the advantage of being improved.

Description

신규한 피리미딘 유도체와 이를 포함하는 유기 발광 소자{New pyrimidine derivative and organic light-emitting devices including the same}TECHNICAL FIELD The present invention relates to a novel pyrimidine derivative and an organic light emitting device including the pyrimidine derivative and organic light-

본 발명의 신규한 피리미딘 유도체와 이를 포함하는 유기 발광 소자에 관한 것으로, 보다 상세하게는 신규한 발광용 화합물인 피리미딘 유도체와 이를 발광층에 포함하는 유기 발광 소자에 관한 것이다.The present invention relates to a novel pyrimidine derivative and an organic light emitting device including the pyrimidine derivative. More particularly, the present invention relates to a novel pyrimidine derivative as a light emitting compound and an organic light emitting device including the pyrimidine derivative in the light emitting layer.

유기 발광 소자는 전자 주입 전극(음극) 과 정공 주입 전극(양극) 사이에 형성된 유기막에 전하를 주입하면 전자와 정공이 쌍을 이룬 후 소멸하면서 빛을 내는 소자이다. 플라스틱 같은 휠 수 있는(flexible) 투명 기판 위에도 소자를 형성할 수 있을 뿐 아니라, 플라즈마 디스플레이 패널(Plasma Display Panel)이나 무기 EL 디스플레이에 비해 낮은 전압에서 (10V이하) 구동이 가능하고, 또한 전력 소모가 비교적 적으며, 색감이 뛰어나다는 장점이 있다. An organic light emitting device is a device that injects electric charge into an organic film formed between an electron injection electrode (cathode) and a hole injection electrode (anode) to form an electron and a hole. It is possible to form a device on a flexible transparent substrate such as a plastic substrate and to operate at a lower voltage (10 V or less) than a plasma display panel or an inorganic EL display, It is relatively small and has an advantage of excellent color.

일반적인 유기 전기발광 소자의 구조는 기판, 양극, 정공을 양극으로부터 받아들이는 정공 주입층, 정공을 이송하는 정공 수송층, 정공과 전자가 결합하여 빛을 내는 발광층, 전자를 음극으로부터 받아들여 발광층으로 전달하는 전자 수송층, 및 음극으로 구성되어 있다. 경우에 따라서는 별도의 발광층 없이 전자 수송층이나 정공 수송층에 소량의 형광 또는 인광성 염료를 도핑하여 발광층을 구성할 수도 있으며, 고분자를 사용할 경우에는 일반적으로 정공 수송층과 발광층, 및 전자 수송층의 역할을 하나의 고분자가 동시에 수행할 수 있다. 두 전극 사이의 유기물 박막층들은 진공증착법 또는 스핀코팅, 잉크젯프린팅, 롤코팅 등의 방법으로 형성되며, 음극으로부터 전자의 효율적인 주입을 위해 별도의 전자 주입층을 삽입하는 경우도 있다.The structure of a general organic electroluminescent device includes a substrate, a cathode, a hole injecting layer for receiving holes from the anode, a hole transporting layer for transporting holes, a light emitting layer for emitting light by combining holes and electrons, An electron transport layer, and a cathode. In some cases, a light emitting layer may be formed by doping a small amount of a fluorescent or phosphorescent dye to an electron transporting layer or a hole transporting layer without a separate light emitting layer. In the case of using a polymer, a hole transporting layer, a light emitting layer, and an electron transporting layer Can be performed simultaneously. The organic thin film layers between the two electrodes are formed by a vacuum deposition method, a spin coating method, an ink jet printing method, a roll coating method, or the like, and a separate electron injection layer may be inserted to efficiently inject electrons from the cathode.

또한 전극과 유기물사이의 계면을 안정화시키거나, 또는 유기 물질의 경우 정공과 전자의 이동속도가 크게 차이가 나므로 적절한 정공 수송층과 전자 수송층을 사용하면 정공과 전자가 발광층으로 효과적으로 전달될 수 있고 발광층에서 정공과 전자의 밀도가 균형을 이루도록 하여 발광효율을 높이기 위하여 유기 발광 소자를 다층 박막 구조로 제작한다.In addition, since the interface between the electrode and the organic material is stabilized, or the organic material has a large difference in the transport speed of holes and electrons, it is possible to effectively transfer holes and electrons to the light emitting layer by using a suitable hole transporting layer and an electron transporting layer. The organic light emitting device is fabricated into a multilayer thin film structure in order to balance the densities of holes and electrons and to increase the luminous efficiency.

한편, 유기 발광 소자에서 발광 효율을 결정하는 가장 중요한 요인은 발광 재료이다. 발광 재료로는 형광 재료가 가장 널리 사용되고 있으나, 전기발광의 메케니즘 상 인광 재료의 개발은 이론적으로 4배까지 발광 효율을 개선시킬 수 있는 가장 좋은 방법중 하나일 수 있어 다양한 연구가 이루어지고 있다.On the other hand, the most important factor for determining the luminous efficiency in an organic light emitting device is a light emitting material. As a light emitting material, a fluorescent material is most widely used, but the development of a phosphorescent material on the mechanism of electroluminescence is one of the best ways to improve the luminous efficiency up to 4 times theoretically, and various studies have been made.

그러나 기존의 개발된 대부분의 재료들은 발광 특성 측면에서는 유리한 면이 있으나, 유리전이온도가 낮고 열적 안정성이 매우 좋지 않아서, 진공하에서 고온 증착 공정을 거칠때 물질이 변하는 등의 단점을 갖고 있다. However, most of the materials developed in the past have advantages in terms of light emission characteristics, but they have disadvantages such as low glass transition temperature and poor thermal stability, which causes materials to change when subjected to a high temperature deposition process under vacuum.

따라서 한국공개특허공보 제 2012-0117501호에서와 같이 우수한 발광 재료개발에 대한 연구가 계속되고 있으나, 여전히 발광효율이 높고 수명특성이 높은 발광 재료에 대한 개발이 요구되고 있다.Therefore, research on the development of excellent luminescent materials as in Korean Patent Laid-Open Publication No. 2012-0117501 is continuing, but development of luminescent materials having high luminescent efficiency and high lifetime characteristics is required.

한국공개특허공보 제 2012-0117501호Korean Patent Laid-Open Publication No. 2012-0117501

본 발명은 신규한 피리미딘 유도체를 제공한다.The present invention provides novel pyrimidine derivatives.

또한 본 발명은 신규한 피리미딘 유도체를 발광층으로 포함하는 유기발광소자를 제공한다.The present invention also provides an organic light emitting device comprising a novel pyrimidine derivative as a light emitting layer.

본 발명은 발광효율이 높고 소자의 수명특성이 높은 신규한 피리미딘 유도체를 발광층에 포함하는 유기발광소자를 제공한다.The present invention provides an organic light emitting device including a novel pyrimidine derivative having high light emitting efficiency and high lifetime characteristics in a light emitting layer.

본 발명의 유기 발광 소자의 발광층에 포함되는 신규한 피리미딘 유도체는 하기 화학식 1로 표시된다.The novel pyrimidine derivative contained in the light emitting layer of the organic light emitting device of the present invention is represented by the following general formula (1).

[화학식 1][Chemical Formula 1]

Figure 112013029045615-pat00001
Figure 112013029045615-pat00001

[상기 화학식 1에서,[In the above formula (1)

R1 내지 R6은 서로 독립적으로 수소, (C1-C30)알킬, (C3-C30)시클로알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이고;R 1 to R 6 are independently of each other hydrogen, (C 1 -C 30) alkyl, (C 3 -C 30) cycloalkyl, (C 6 -C 30) aryl or (C 3 -C 30) heteroaryl;

R7 내지 R9는 서로 독립적으로 수소, (C1-C30)알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이며, R8과 R9는 (C3-C30)알킬렌 또는 (C3-C30)알케닐렌으로 연결되어 지환족 고리 및 단일환 또는 다환의 방향족 고리를 형성할 수 있으며, 상기 형성된 지환족 고리 및 단일환 또는 다환의 방향족 고리의 탄소 원자는 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자로 치환될 수 있고;R 7 and R 9 are independently from each other hydrogen, (C 1 -C 30) alkyl, (C 6 -C 30) aryl or (C 3 -C 30) heteroaryl; R 8 and R 9 are (C3-C30) -C30) alkenylene to form an alicyclic ring and a monocyclic or polycyclic aromatic ring, and the carbon atom of the formed alicyclic ring and the monocyclic or polycyclic aromatic ring is selected from nitrogen, oxygen and sulfur Which may be substituted with one or more heteroatoms;

L은 (C6-C30)아릴렌 또는 (C3-C30)헤테로아릴렌이며;L is (C6-C30) arylene or (C3-C30) heteroarylene;

n은 0 내지 3의 정수이며;n is an integer from 0 to 3;

상기 R1 내지 R6의 알킬, 시클로알킬, 아릴 및 헤테로아릴 또는 R7 내지 R9의 알킬, 아릴, 헤테로아릴, 알킬렌 및 알케닐렌은 (C1-C30)알킬, 할로(C1-C30)알킬, 할로겐, 시아노, (C3-C30)시클로알킬, (C1-C30)알콕시, (C6-C30)아릴옥시, (C6-C30)아릴, (C6-C30)아르(C1-C30)알킬, (C1-C30)알킬(C6-C30)아릴, (C3-C30)헤테로아릴, (C1-C30)알킬이 치환된 (C3-C30)헤테로아릴, (C6-C30)아릴이 치환된 (C3-C30)헤테로아릴, 모노 또는 디(C1-C30)알킬아미노, 모노 또는 디(C6-C30)아릴아미노, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 나이트로 및 하이드록시로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있다.]The alkyl, cycloalkyl, aryl and heteroaryl of R 1 to R 6 or the alkyl, aryl, heteroaryl, alkylene and alkenylene of R 7 to R 9 are independently selected from the group consisting of (C 1 -C 30) alkyl, halo (C 1 -C 30) (C1-C30) alkyl, (C6-C30) aryl, (C6-C30) aryl (C3-C30) aryl (C3-C30) heteroaryl, (C3-C30) heteroaryl substituted with (C1-C30) alkylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, mono- or di (C6-C30) arylsilyl, nitro, and hydroxy.

본 발명의 상기 화학식 1로 표시되는 신규한 피리미딘 유도체를 발광층에 포함하는 유기 발광 소자는 피리미딘과 페닐기가 하나 이상의 아릴렌 또는 헤테로아릴렌으로 연결되거나, 화학결합으로 연결되어 안정하며, 높은 전자밀도를 가져 발광효율이 높다.The organic light emitting device comprising the novel pyrimidine derivative represented by Formula 1 of the present invention in the light emitting layer is a compound in which pyrimidine and phenyl group are connected by one or more arylene or heteroarylene, The density is high and the luminous efficiency is high.

본 발명의 발광소자의 일 실시예에 따른 상기 화학식 1에서, In the light emitting device of the present invention,

R1 내지 R6은 서로 독립적으로 (C1-C30)알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이고;R 1 to R 6 are, independently of each other, (C 1 -C 30) alkyl, (C 6 -C 30) aryl or (C 3 -C 30) heteroaryl;

R7 내지 R9는 서로 독립적으로 (C1-C30)알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이며, R8과 R9는 (C3-C30)알킬렌 또는 (C3-C30)알케닐렌으로 연결되어 지환족 고리 및 단일환 또는 다환의 방향족 고리를 형성할 수 있으며, 상기 형성된 지환족 고리 및 단일환 또는 다환의 방향족 고리의 탄소 원자는 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자로 치환될 수 있고;R 7 and R 9 are each independently (C 1 -C 30) alkyl, (C 6 -C 30) aryl or (C 3 -C 30) heteroaryl; R 8 and R 9 are ) Alkenylene to form an alicyclic ring and a monocyclic or polycyclic aromatic ring, and the carbon atom of the formed alicyclic ring and the monocyclic or polycyclic aromatic ring may be substituted with at least one group selected from nitrogen, oxygen and sulfur Lt; / RTI > may be substituted with a heteroatom;

L은 (C6-C30)아릴렌이며;L is (C6-C30) arylene;

n은 1 내지 3의 정수이며;n is an integer from 1 to 3;

상기 R1 내지 R6의 알킬, 아릴 및 헤테로아릴 또는 R7 내지 R9의 알킬, 아릴, 헤테로아릴, 알킬렌 및 알케닐렌은 (C1-C30)알킬, 할로(C1-C30)알킬, 할로겐, 시아노, (C1-C30)알콕시, (C6-C30)아릴, (C3-C30)헤테로아릴, (C1-C30)알킬이 치환된 (C3-C30)헤테로아릴, 나이트로 및 하이드록시로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있다.The alkyl, aryl and heteroaryl of R 1 to R 6 or the alkyl, aryl, heteroaryl, alkylene and alkenylene of R 7 to R 9 are independently selected from the group consisting of (C 1 -C 30) alkyl, halo (C 1 -C 30) (C3-C30) heteroaryl substituted with (C1-C30) alkyl, cyano, (C1-C30) alkoxy, ≪ / RTI >

바람직하게 본 발명의 발광소자의 일 실시예에 따른 상기 화학식 1은 하기 화학식 2로 표시될 수 있다.Preferably, Formula 1 according to an embodiment of the light emitting device of the present invention may be represented by Formula 2 below.

[화학식 2](2)

Figure 112013029045615-pat00002
Figure 112013029045615-pat00002

[상기 화학식 2에서, [In the formula (2)

R1 내지 R6은 서로 독립적으로 (C1-C30)알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이고;R 1 to R 6 are, independently of each other, (C 1 -C 30) alkyl, (C 6 -C 30) aryl or (C 3 -C 30) heteroaryl;

R7은 (C6-C30)아릴이며;R < 7 > is (C6-C30) aryl;

L은 (C6-C30)아릴렌이며;L is (C6-C30) arylene;

n은 1 내지 2의 정수이며;n is an integer of 1 to 2;

상기 R1 내지 R6의 알킬, 아릴 및 헤테로아릴 또는 R7의 아릴은 (C1-C30)알킬, 할로(C1-C30)알킬, 할로겐, 시아노, (C1-C30)알콕시, (C6-C30)아릴, (C3-C30)헤테로아릴, (C1-C30)알킬이 치환된 (C3-C30)헤테로아릴, 나이트로 및 하이드록시로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있다.]Aryl in the above R 1 to R 6 alkyl, aryl and heteroaryl, or R 7 a is (C1-C30) alkyl, halo (C1-C30) alkyl, halogen, cyano, (C1-C30) alkoxy, (C6-C30 (C3-C30) heteroaryl, (C3-C30) heteroaryl, (C3-C30) heteroaryl, nitro, and hydroxy.

본 발명의 일 실시예에 따른 화학식 2를 발광층에 포함하는 유기 발광 소자는 피리미딘이 나프탈렌과 융합된 고리, 즉 벤조퀴나졸린(benzo[h]quinazoline)을 가져 높은 발광효율을 가진다.The organic light emitting device comprising the light emitting layer of Formula 2 according to an embodiment of the present invention has a high luminous efficiency due to a ring fused with pyrimidine naphthalene, that is, benzo [ h ] quinazoline.

본 발명의 일 실시예에 따른 화학식 2에서, 한정이 있는 것은 아니나, 상기 R1 내지 R6은 서로 독립적으로 (C1-C30)알킬이거나 하기 구조에서 선택될 수 있다.In Formula (2) according to an embodiment of the present invention, R 1 to R 6 are independently (C 1 -C 30) alkyl or may be selected from the following structures.

Figure 112013029045615-pat00003
Figure 112013029045615-pat00003

[상기 R', R'' 및 R'''는 서로 독립적으로 수소, (C1-C30)알킬, (C6-C30)아릴, (C3-C30)헤테로아릴 또는 (C1-C30)알킬(C6-C30)아릴이다.](C6-C30) aryl, (C3-C30) heteroaryl or (C1-C30) alkyl (C6-C30) heteroaryl, wherein R ', R "and R' C30) aryl.]

바람직하게는 본 발명의 상기 화학식 2를 발광층에 포함하는 유기 발광 소자의 상기 화학식 2에서, R1 내지 R6에서 하나는 반드시 상기 구조식을 가질 수 있다.Preferably, in Formula 2 of the organic light emitting device having Formula 2 of the present invention, one of R 1 to R 6 may have the formula.

바람직하게 발광효율측면에서 본 발명의 일 실시예에 따른 상기 화학식 1은 하기 화학식 3으로 표시될 수 있다. Preferably, Formula 1 according to an embodiment of the present invention may be represented by Formula 3 in terms of luminous efficiency.

[화학식 3](3)

Figure 112013029045615-pat00004
Figure 112013029045615-pat00004

[상기 화학식 3에서,[Formula 3]

R7은 (C6-C30)아릴이며;R < 7 > is (C6-C30) aryl;

L은 (C6-C30)아릴렌이며;L is (C6-C30) arylene;

n은 1 내지 2의 정수이며;n is an integer of 1 to 2;

R11 또는 R12는 서로 독립적으로 수소, (C1-C30)알킬 또는 (C6-C30)아릴이며;R 11 or R 12 independently from each other are hydrogen, (C 1 -C 30) alkyl or (C 6 -C 30) aryl;

o는 1 내지 4의 정수이다.]and o is an integer of 1 to 4.]

보다 구체적으로 본 발명의 일 실시예에 따른 상기 화학식 1로 표시되는 피리미딘 유도체는 하기 화합물에서 선택될 수 있으나, 이에 한정이 있는 것은 아니다.More specifically, the pyrimidine derivative represented by Formula 1 according to an embodiment of the present invention may be selected from the following compounds, but is not limited thereto.

Figure 112013029045615-pat00005
Figure 112013029045615-pat00005

Figure 112013029045615-pat00006
Figure 112013029045615-pat00006

Figure 112013029045615-pat00007
Figure 112013029045615-pat00007

Figure 112013029045615-pat00008
Figure 112013029045615-pat00008

Figure 112013029045615-pat00009
Figure 112013029045615-pat00009

Figure 112013029045615-pat00010
Figure 112013029045615-pat00010

Figure 112013029045615-pat00011
Figure 112013029045615-pat00012
Figure 112013029045615-pat00011
Figure 112013029045615-pat00012

Figure 112013029045615-pat00013

Figure 112013029045615-pat00013

Figure 112013029045615-pat00014
Figure 112013029045615-pat00015
Figure 112013029045615-pat00014
Figure 112013029045615-pat00015

Figure 112013029045615-pat00016
Figure 112013029045615-pat00016

Figure 112013029045615-pat00017
Figure 112013029045615-pat00017

Figure 112013029045615-pat00018
Figure 112013029045615-pat00018

본 발명의 일 실시예에 따른 유기 발광 소자는 제1전극; 제2전극; 및 상기 제1전극과 제2전극 사이에 개재되는 1층 이상의 유기물층으로 이루어져 있으며, 상기 유기물층은 상기 발광용 화합물, 본 발명의 상기 화학식 1로 표시되는 피리미딘 유도체가 포함된 발광층을 포함할 수 있다.An organic light emitting device according to an embodiment of the present invention includes a first electrode; A second electrode; And at least one organic compound layer interposed between the first electrode and the second electrode. The organic compound layer may include the light-emitting compound and the light-emitting layer containing the pyrimidine derivative represented by Formula 1 of the present invention .

또한 본 발명은 상기 화학식 1로 표시되는 피리미딘 유도체를 제공한다.The present invention also provides a pyrimidine derivative represented by the above formula (1).

[화학식 1][Chemical Formula 1]

Figure 112013029045615-pat00019
Figure 112013029045615-pat00019

[상기 화학식 1에서,[In the above formula (1)

R1 내지 R6은 서로 독립적으로 수소, (C1-C30)알킬, (C3-C30)시클로알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이고;R 1 to R 6 are independently of each other hydrogen, (C 1 -C 30) alkyl, (C 3 -C 30) cycloalkyl, (C 6 -C 30) aryl or (C 3 -C 30) heteroaryl;

R7 내지 R9는 서로 독립적으로 수소, (C1-C30)알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이며, R8과 R9는 (C3-C30)알킬렌 또는 (C3-C30)알케닐렌으로 연결되어 지환족 고리 및 단일환 또는 다환의 방향족 고리를 형성할 수 있으며, 상기 형성된 지환족 고리 및 단일환 또는 다환의 방향족 고리의 탄소 원자는 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자로 치환될 수 있고;R 7 and R 9 are independently from each other hydrogen, (C 1 -C 30) alkyl, (C 6 -C 30) aryl or (C 3 -C 30) heteroaryl; R 8 and R 9 are (C3-C30) -C30) alkenylene to form an alicyclic ring and a monocyclic or polycyclic aromatic ring, and the carbon atom of the formed alicyclic ring and the monocyclic or polycyclic aromatic ring is selected from nitrogen, oxygen and sulfur Which may be substituted with one or more heteroatoms;

L은 (C6-C30)아릴렌 또는 (C3-C30)헤테로아릴렌이며;L is (C6-C30) arylene or (C3-C30) heteroarylene;

n은 0 내지 3의 정수이며;n is an integer from 0 to 3;

상기 R1 내지 R6의 알킬, 시클로알킬, 아릴 및 헤테로아릴 또는 R7 내지 R9의 알킬, 아릴, 헤테로아릴, 알킬렌 및 알케닐렌은 (C1-C30)알킬, 할로(C1-C30)알킬, 할로겐, 시아노, (C3-C30)시클로알킬, (C1-C30)알콕시, (C6-C30)아릴옥시, (C6-C30)아릴, (C6-C30)아르(C1-C30)알킬, (C1-C30)알킬(C6-C30)아릴, (C3-C30)헤테로아릴, (C1-C30)알킬이 치환된 (C3-C30)헤테로아릴, (C6-C30)아릴이 치환된 (C3-C30)헤테로아릴, 모노 또는 디(C1-C30)알킬아미노, 모노 또는 디(C6-C30)아릴아미노, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 나이트로 및 하이드록시로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있다.]The alkyl, cycloalkyl, aryl and heteroaryl of R 1 to R 6 or the alkyl, aryl, heteroaryl, alkylene and alkenylene of R 7 to R 9 are independently selected from the group consisting of (C 1 -C 30) alkyl, halo (C 1 -C 30) (C1-C30) alkyl, (C6-C30) aryl, (C6-C30) aryl (C3-C30) aryl (C3-C30) heteroaryl, (C3-C30) heteroaryl substituted with (C1-C30) alkylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, mono- or di (C6-C30) arylsilyl, nitro, and hydroxy.

본 발명의 일 실시예에 따른 상기 화학식 1은 하기 화학식 2로 표시될 수 있다.The formula (1) according to an embodiment of the present invention may be represented by the following formula (2).

[화학식 2](2)

Figure 112013029045615-pat00020
Figure 112013029045615-pat00020

[상기 화학식 2에서, [In the formula (2)

R1 내지 R6은 서로 독립적으로 (C1-C30)알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이고;R 1 to R 6 are, independently of each other, (C 1 -C 30) alkyl, (C 6 -C 30) aryl or (C 3 -C 30) heteroaryl;

R7은 (C6-C30)아릴이며;R < 7 > is (C6-C30) aryl;

L은 (C6-C30)아릴렌이며;L is (C6-C30) arylene;

n은 1 내지 2의 정수이며;n is an integer of 1 to 2;

상기 R1 내지 R6의 알킬, 아릴 및 헤테로아릴 또는 R7의 아릴은 (C1-C30)알킬, 할로(C1-C30)알킬, 할로겐, 시아노, (C1-C30)알콕시, (C6-C30)아릴, (C3-C30)헤테로아릴, (C1-C30)알킬이 치환된 (C3-C30)헤테로아릴, 나이트로 및 하이드록시로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있다.]Aryl in the above R 1 to R 6 alkyl, aryl and heteroaryl, or R 7 a is (C1-C30) alkyl, halo (C1-C30) alkyl, halogen, cyano, (C1-C30) alkoxy, (C6-C30 (C3-C30) heteroaryl, (C3-C30) heteroaryl, (C3-C30) heteroaryl, nitro, and hydroxy.

본 발명의 피리미딘 유도체는 하기 반응식으로 예시하였으나, 이에 한정되는 것은 아니며, 공지의 유기반응을 통하여 제조될 수 있음을 물론이다.The pyrimidine derivatives of the present invention are illustrated by the following reaction schemes, but the present invention is not limited thereto and may be prepared through known organic reactions.

[반응식][Reaction Scheme]

Figure 112013029045615-pat00021
Figure 112013029045615-pat00021

[상기 반응식에서[In the above reaction formula

R1 내지 R9, L 및 n은 상기 화학식 1의 정의와 동일하다.]R 1 to R 9 , L and n are the same as defined in the above formula 1.]

본 발명의 피리미딘 유도체를 발광층에 포함하는 유기 발광 소자는 휘도가 높고 발광효율이 좋을 뿐만 아니라 소자의 수명특성이 뛰어나다.The organic light-emitting device including the pyrimidine derivative of the present invention in the light-emitting layer has high luminance, high luminous efficiency, and excellent lifetime characteristics of the device.

도 1은 실시예 5 내지 8 및 비교예 1에서 제작된 유기 발광 소자의 효율(cd/A)대 휘도(cd/㎡)를 나타낸 그래프이다.FIG. 1 is a graph showing the efficiency (cd / A) vs. luminance (cd / m 2) of the organic light emitting device manufactured in Examples 5 to 8 and Comparative Example 1.

이하, 본 발명은 하기의 실시예에 의하여 보다 더 잘 이해될 수 있으며, 하기의 실시예는 본 발명의 예시 목적을 위한 것으로서 본 발명의 보호 범위를 제한하고자 하는 것은 아니다.Hereinafter, the present invention will be better understood by reference to the following examples, and the following examples are for illustrative purposes only and are not intended to limit the scope of protection of the present invention.

[[ 실시예Example 1] 화합물 1의 제조 1] Preparation of compound 1

Figure 112013029045615-pat00022
Figure 112013029045615-pat00022

Figure 112013029045615-pat00023
Figure 112013029045615-pat00023

화합물compound 1-a  1-a 의 제조Manufacturing

500 mL-3구 둥근바닥플라스크에 1-테트라론 30 g(205 mmol)과 4-브로모벤잘데히드 39.8 g(215 mmol)을 넣고 메탄올 200 mL에 녹인 후 0 ℃에서 수산화나트륨 10.2 g(256 mmol)을 천천히 넣고 상온에서 12 시간 동안 교반하였다. 냉각 후 석출된 고체를 감압 여과로 분리하고 메탄올로 세정하여 연한 노란색의 고체 화합물 37.4 g(수율 : 58 %) 을 얻었다. 30 g (205 mmol) of 1-tetralone and 39.8 g (215 mmol) of 4-bromobenzaldehyde were placed in a 500 mL-3-necked round bottom flask and dissolved in 200 mL of methanol. Then, 10.2 g ) Was slowly added and stirred at room temperature for 12 hours. The precipitated solid was separated by filtration under reduced pressure and washed with methanol to obtain 37.4 g (yield: 58%) of a pale yellow solid compound.

1H NMR(CDCl3) δ[ppm]: 2.97(t, 2H), 3.10(t, 2H), 7.28(s, 1H), 7.33(d, 2H), 7.41(t, 1H), 7.52(t, 1H), 7.56(d, 2H), 7.79(s, 1H), 8.15(d, 1H)
1 H NMR (CDCl 3) δ [ppm]: 2.97 (t, 2H), 3.10 (t, 2H), 7.28 (s, 1H), 7.33 (d, 2H), 7.41 (t, 1H), 7.52 (t , 7.56 (d, 2H), 7.79 (s, IH), 8.15 (d, IH)

화합물compound 1-b  1-b 의 제조Manufacturing

250 mL-3구 둥근바닥플라스크에 화합물 1-a 5 g(15.9 mmol)과 벤자미딘하이드로클로라이드 2.7 g(17.5 mmol), 수산화나트륨 0.95 g(23.9 mmol)을 넣고 에탄올 50 mL에 녹인 후 12 시간 동안 환류하였다. 냉각 후 석출된 고체를 감압 여과한 후 실리카겔 컬럼 (헥산 : 메틸렌 클로라이드 = 1 : 1)으로 분리하여 흰색의 고체 화합물 4.02 g(수율 : 60 %) 을 얻었다. 5 g (15.9 mmol) of compound 1-a, 2.7 g (17.5 mmol) of benzamidine hydrochloride and 0.95 g (23.9 mmol) of sodium hydroxide were placed in a 250 mL three-neck round bottom flask and dissolved in 50 mL of ethanol. Lt; / RTI > After cooling, the precipitated solid was filtered off under reduced pressure, and the residue was separated by silica gel column (hexane: methylene chloride = 1: 1) to obtain 4.02 g of a white solid compound (yield: 60%).

1H NMR(CDCl3) δ[ppm]: 2.93(t, 2H), 3.08(t, 2H), 7.28(s, 1H), 7.45-7.54(m, 5H), 7.62-7.70(m, 4H), 8.60-8.66(m, 3H)
1 H NMR (CDCl 3) δ [ppm]: 2.93 (t, 2H), 3.08 (t, 2H), 7.28 (s, 1H), 7.45-7.54 (m, 5H), 7.62-7.70 (m, 4H) , 8.60-8.66 (m, 3H)

화합물compound 1-c  1-c 의 제조Manufacturing

250 mL-3구 둥근바닥플라스크에 화합물 1-b 5 g(12.1 mmol)과 2,3-디클로로-5,6-디사이아노벤조퀴논 2.8 g(12.3 mmol)을 넣고 1,2-디클로로벤젠 50 mL에 녹인 후 120 ℃에서 12 시간 동안 환류하였다. 냉각 후 물과 메틸렌 클로라이드로 추출한 후 메탄올로 재결정하여 흰색의 고체 화합물 4.32g(수율 : 86 %) 을 얻었다. 5 g (12.1 mmol) of the compound 1-b and 2.8 g (12.3 mmol) of 2,3-dichloro-5,6-dicyanobenzoquinone were placed in a 250 mL-3-necked round bottom flask, mL and then refluxed at 120 ° C for 12 hours. After cooling, the reaction mixture was extracted with water and methylene chloride, and recrystallized from methanol to obtain 4.32 g (yield: 86%) of a white solid compound.

1H NMR(CDCl3) δ[ppm]: 7.52-7.58(m, 3H), 7.74-7.80(m, 7H), 7.89-7.93(m, 2H), 8.81(d, 2H), 9.54(m, 1H)
1 H NMR (CDCl 3) δ [ppm]: 7.52-7.58 (m, 3H), 7.74-7.80 (m, 7H), 7.89-7.93 (m, 2H), 8.81 (d, 2H), 9.54 (m, 1H)

화합물compound 1-d  1-d 의 제조Manufacturing

250 mL-3구 둥근바닥플라스크에 화합물 1-c 15 g(36.5 mmol)과 2-메틸-3-부틴-2-올 3.2 g(38.3 mmol), 디클로로비스트리페닐포스핀팔라듐(II) 0.26g(0.4 mmol), 트리페닐포스핀 0.48g(1.8 mmol), 요오드화구리 0.35g(1.8 mmol), 트리에틸아민 75 ml를 넣고 4시간 동안 환류, 교반한다. 감압 여과 후 물로 씻어주어 고체 화합물 14.2g (수율 : 94 %) 를 얻었다. To a 250 mL three-neck round bottom flask was added 15 g (36.5 mmol) of compound 1-c, 3.2 g (38.3 mmol) of 2-methyl-3-butyn- 0.48 g (1.8 mmol) of triphenylphosphine, 0.35 g (1.8 mmol) of copper iodide, and 75 ml of triethylamine were added to the solution, and the mixture was refluxed for 4 hours and stirred. After filtration under reduced pressure, the residue was washed with water to obtain 14.2 g (yield: 94%) of a solid compound.

1H NMR(CDCl3) δ[ppm]: 7.32-7.36(m, 3H), 7.42(t, 2H), 7.58(d, 4H), 7.64-7.69(m, 4H), 7.84(m, 1H), 7.87(d, 1H), 1.62(s, 6H), 1.29(s, 1H)
1 H NMR (CDCl 3) δ [ppm]: 7.32-7.36 (m, 3H), 7.42 (t, 2H), 7.58 (d, 4H), 7.64-7.69 (m, 4H), 7.84 (m, 1H) , 7.87 (d, 1 H), 1.62 (s, 6 H), 1.29 (s, 1 H)

화합물compound 1-e  1-e 의 제조Manufacturing

250 mL-3구 둥근바닥플라스크에 화합물 1-d 14 g(33.8mmol)과 수산화칼륨 0.5 g(10.1 mmol)와 톨루엔 70 mL를 넣고 3시간 동안 환류, 교반한다. 반응 종료 후에 물 투입하고, 메틸렌 클로라이드로 추출한다. 황산마그네슘으로 수분제거 후에 감압 농축하여, 얻어진 고체를 헥산으로 씻어준다. 연노란색 고체 화합물 9.5 g (수율 : 79 %) 얻었다. 14 g (33.8 mmol) of the compound 1-d, 0.5 g (10.1 mmol) of potassium hydroxide and 70 mL of toluene are placed in a 250 mL-3-necked round bottom flask and refluxed and stirred for 3 hours. After completion of the reaction, water is added, and the mixture is extracted with methylene chloride. After removing moisture with magnesium sulfate, the mixture was concentrated under reduced pressure, and the resulting solid was washed with hexane. 9.5 g (yield: 79%) of yellow solid compound was obtained.

1H NMR(CDCl3) δ[ppm]: 7.32-7.36(m, 3H), 7.41(t, 2H), 7.59(s, 4H), 7.64-7.69(m, 4H), 7.84(m, 1H), 7.89(d, 1H), 3.13(s, 1H)
1 H NMR (CDCl 3) δ [ppm]: 7.32-7.36 (m, 3H), 7.41 (t, 2H), 7.59 (s, 4H), 7.64-7.69 (m, 4H), 7.84 (m, 1H) , 7.89 (d, 1 H), 3.13 (s, 1 H)

화합물compound 1-f  1-f 의 제조Manufacturing

500 mL-3구 둥근바닥플라스크에 테트라히드로퓨란(THF) 200 mL 와 요오드페닐카바졸 20 g(54.2 mmol), 화합물 1-e 23 g(65 mmol), 트리에틸아민 21.9 g(216.7 mmol), 디클로로비스트리페닐포스핀팔라듐(II) 0.76 g(1.1 mmol), 요오드화구리 0.21 g(1.1 mmol) 를 넣고 12시간 동안 환류, 교반한다. 반응 종료 후에 감압 여과하고, 얻어진 고체를 헥산으로 재결정하여 흰색의 고체 화합물 10.1g (수율 : 40 %) 얻었다. 200 mL of tetrahydrofuran (THF), 20 g (54.2 mmol) of iodophenylcarbazole, 23 g (65 mmol) of the compound 1-e and 21.9 g (216.7 mmol) of triethylamine were added to a 500 mL- 0.76 g (1.1 mmol) of dichlorobistriphenylphosphine palladium (II) and 0.21 g (1.1 mmol) of copper iodide were added thereto, and the mixture was refluxed for 12 hours and stirred. After completion of the reaction, the mixture was filtered under reduced pressure, and the resulting solid was recrystallized from hexane to obtain 10.1 g (yield: 40%) of a white solid compound.

1H NMR(CDCl3) δ[ppm]: 7.15-7.18(t, 1H), 7.24-7.30(m, 2H), 7.38-7.41(t, 1H), 7.45-7.50(m, 7H), 7.62-7.76(m, 11H), 7.80(d, 2H), 7.95-7.97(m, 1H), 8.09(d, 2H)
1 H NMR (CDCl 3) δ [ppm]: 7.15-7.18 (t, 1H), 7.24-7.30 (m, 2H), 7.38-7.41 (t, 1H), 7.45-7.50 (m, 7H), 7.62- 2H), 7.95-7.97 (m, 1H), 8.09 (d, 2H)

화합물compound 1-g  1-g 의 제조Manufacturing

250 mL-3구 둥근바닥플라스크에 1,3-디페닐-2-프로판온 10 g(48 mmol) 과 벤질 10 g(48 mmol) 을 메탄올 150 ml 에 녹인 후 수산화칼륩 4 g(72 mmol) 을 천천히 투입한다. 5시간 동안 환류하고 감압 여과 후 검은색 고체 화합물 10.2 g (수율 : 55 %) 를 얻었다.10 g (48 mmol) of 1,3-diphenyl-2-propanone and 10 g (48 mmol) of benzyl were dissolved in 150 ml of methanol, and 4 g (72 mmol) of potassium hydroxide was added to a 250 ml- Slowly. After refluxing for 5 hours and filtration under reduced pressure, 10.2 g (yield: 55%) of a black solid compound was obtained.

1H NMR(DMSO) δ[ppm]: 7.34(t, 1H), 7.43(m, 7H), 7.58(d, 1H), 7.83(d, 1H) 1 H NMR (DMSO) δ [ ppm]: 7.34 (t, 1H), 7.43 (m, 7H), 7.58 (d, 1H), 7.83 (d, 1H)

화합물 compound 1One 의 제조 Manufacturing

500 mL-3구 둥근바닥플라스크에 화합물 1-g 10 g(26 mmol) 과 화합물 1-f 15.5 g(26 mmol)을 넣고 디페닐에테르 200 ml 에 녹인다. 4시간 환류 반응 후에 헥산 140 ml 를 투입한다. 형성된 갈색 고체를 감압여과 후 실리카겔 컬럼 (Hexane: EA = 3:1) 으로 분리하여 백색의 고체 화합물 7.3 g(수율 : 70 %) 을 얻었다. Add 10 g (26 mmol) of the compound 1-g and 15.5 g (26 mmol) of the compound 1-f to a 500 mL-3-necked round bottom flask and dissolve in 200 ml of diphenyl ether. After refluxing for 4 hours, 140 ml of hexane is added. The resulting brown solid was filtered off under reduced pressure, and the residue was separated by silica gel column (Hexane: EA = 3: 1) to obtain 7.3 g (yield: 70%) of a white solid compound.

1H NMR(CDCl3) δ[ppm]: 6.81(t, 1H), 6.92(t, 1H), 7.04(t, 2H), 7.12(d, 1H), 7.22(d, 1H), 7.28-7.41(m, 16H), 7.53-7.55(m, 4H), 7.62-7.67(m, 9H), 7.76(d, 2H), 7.86(d, 2H), 7.92(d, 1H), 8.11(d, 2H), 8.16(d, 1H), 8.22(d, 2H), 8.45(d, 1H) 8.64(s, 1H) 1 H NMR (CDCl 3) δ [ppm]: 6.81 (t, 1H), 6.92 (t, 1H), 7.04 (t, 2H), 7.12 (d, 1H), 7.22 (d, 1H), 7.28-7.41 (m, 4H), 7.62-7.67 (m, 9H), 7.76 (d, 2H), 7.86 (d, 2H), 7.92 ), 8.16 (d, IH), 8.22 (d, 2H), 8.45

MALDI-TOF MS: m/z 399.28, cal. 399.94
MALDI-TOF MS: m / z 399.28, cal. 399.94

[실시예 2] 화합물 2의 제조[Example 2] Preparation of Compound 2

Figure 112013029045615-pat00024

Figure 112013029045615-pat00024

화합물compound 2-a  2-a 의 제조Manufacturing

1000mL-3구 둥근바닥플라스크에 3-브로모벤잘데히드 35 g( 239 mmol)과 1-테트라론 46.6 g(252 mmol)을 넣고 에탄올 200 mL에 녹인 후 0 ℃에서 수산화나트륨 11.9 g(299 mmol)을 천천히 넣고 상온에서 12 시간 동안 교반하였다. 냉각 후 석출된 고체를 감압 여과로 분리하고 메탄올로 세정하여 연한 노란색의 고체 화합물 64.2 g(수율 : 85 %) 을 얻었다. 35 g (239 mmol) of 3-bromobenzaldehyde and 46.6 g (252 mmol) of 1-tetralone were added to a 1000 mL-3-necked round bottom flask and dissolved in 200 mL of ethanol. Then, 11.9 g (299 mmol) And the mixture was stirred at room temperature for 12 hours. The precipitated solid was separated by filtration under reduced pressure and washed with methanol to obtain 64.2 g (yield: 85%) of a pale yellow solid compound.

1H NMR(CDCl3) δ[ppm]: 2.98(t, 2H), 3.12(t, 2H), 7.27-7.41(m, 4H), 7.49-7.54(m, 2H), 7.59(s, 1H), 7.79(s, 1H), 8.14(d, 1H)
1 H NMR (CDCl 3) δ [ppm]: 2.98 (t, 2H), 3.12 (t, 2H), 7.27-7.41 (m, 4H), 7.49-7.54 (m, 2H), 7.59 (s, 1H) , 7.79 (s, 1 H), 8.14 (d, 1 H)

화합물compound 2-b  2-b 의 제조Manufacturing

1000mL-3구 둥근바닥플라스크에 화합물 2-a 60 g(190 mmol)과 벤자미딘하이드로클로라이드 33 g(210 mmol), 수산화나트륨 11.4 g(290 mmol)을 넣고 에탄올 600 mL에 녹인 후 12 시간 동안 환류하였다. 냉각 후 석출된 고체를 감압 여과한 후 실리카겔 컬럼 (헥산 : 메틸렌 클로라이드 = 1 : 1)으로 분리하여 연한 노란색의 고체 화합물 54.4 g(수율 : 68 %) 을 얻었다. 60 g (190 mmol) of compound 2-a, 33 g (210 mmol) of benzamidine hydrochloride and 11.4 g (290 mmol) of sodium hydroxide were added to a 1000 mL-3-necked round bottom flask and dissolved in 600 mL of ethanol. Lt; / RTI > After cooling, the precipitated solid was filtered off under reduced pressure and then separated by silica gel column (hexane: methylene chloride = 1: 1) to obtain 54.4 g of a pale yellow solid compound (yield: 68%).

1H NMR(CDCl3) δ[ppm]: 2.87(t, 2H), 3.02(t, 2H), 7.24(s, 1H), 7.34-7.61(m, 8H), 7.87(s, 1H), 8.56-8.63(m, 3H)
1 H NMR (CDCl 3) δ [ppm]: 2.87 (t, 2H), 3.02 (t, 2H), 7.24 (s, 1H), 7.34-7.61 (m, 8H), 7.87 (s, 1H), 8.56 -8.63 (m, 3 H)

화합물compound 2-c  2-c 의 제조Manufacturing

1000mL-3구 둥근바닥플라스크에 화합물 2-b 62.7 g(151 mmol)과 2,3-디클로로-5,6-디사이아노벤조퀴논 34 g(151 mmol)을 넣고 1,2-디클로로벤젠 600 mL에 녹인 후 120 ℃에서 12 시간 동안 환류하였다. 냉각 후 물과 메틸렌 클로라이드로 추출한 후 실리카겔 컬럼 (헥산 : 메틸렌 클로라이드 = 1 : 1)으로 분리하여 연한 노란색의 고체 화합물 22.42 g(수율 : 36 %)을 얻었다. 62.7 g (151 mmol) of the compound 2-b and 34 g (151 mmol) of 2,3-dichloro-5,6-dicyanobenzoquinone were placed in a 1000 mL three-necked round bottom flask, and 600 mL And then refluxed at 120 ° C for 12 hours. After cooling, the reaction mixture was extracted with water and methylene chloride, and then separated by a silica gel column (hexane: methylene chloride = 1: 1) to obtain 22.42 g of a pale yellow solid compound (yield: 36%).

1H NMR(CDCl3) δ[ppm]: 7.47-7.59(m, 4H), 7.72-8.07(m, 8H), 8.82(d, 2H), 9.54(m, 1H)
1 H NMR (CDCl 3 )? [Ppm]: 7.47-7.59 (m, 4H), 7.72-8.07 (m, 8H), 8.82 (d, 2H), 9.54

화합물compound 2-d  2-d 의 제조Manufacturing

250 mL-3구 둥근바닥플라스크에 화합물 2-c 20 g(48.6 mmol)과 2-메틸-3-부틴-2-올 4.3 g(51.1 mmol), 디클로로비스트리페닐포스핀팔라듐(II) 0.3 g(0.5 mmol), 트리페닐포스핀 0.6 g(2.4 mmol), 요오드화구리 0.4 g(2.4 mmol), 트리에틸아민 100 ml를 넣고 4시간 동안 환류, 교반한다. 감압 여과 후 물로 씻어주어 고체 화합물 18.1 g (수율 : 90 %) 를 얻었다. To a 250 mL three-neck round bottom flask was added 20 g (48.6 mmol) of compound 2-c, 4.3 g (51.1 mmol) of 2-methyl-3-butyn- (0.5 mmol), triphenylphosphine (0.6 g, 2.4 mmol), copper iodide (0.4 g, 2.4 mmol) and triethylamine (100 ml) were added and the mixture was refluxed for 4 hours and stirred. After filtration under reduced pressure, the filtrate was washed with water to obtain 18.1 g of a solid compound (yield: 90%).

1H NMR(CDCl3) δ[ppm]: 7.32-7.43(m, 6H), 7.53-7.55(d, 1H), 7.64-7.72(m, 5H), 7.85(m, 1H), 7.94(d, 1H), 1.54(s, 6H), 1.39(s, 1H)
1 H NMR (CDCl 3) δ [ppm]: 7.32-7.43 (m, 6H), 7.53-7.55 (d, 1H), 7.64-7.72 (m, 5H), 7.85 (m, 1H), 7.94 (d, 1H), 1.54 (s, 6H), 1.39 (s, 1 H)

화합물compound 2-e  2-e 의 제조Manufacturing

250 mL-3구 둥근바닥플라스크에 화합물 2-d 18 g(43.4 mmol)과 수산화칼륨 0.7 g(13 mmol)와 톨루엔 90 mL를 넣고 3시간 동안 환류, 교반한다. 반응 종료 후에 물 투입하고, 메틸렌 클로라이드로 추출한다. 황산마그네슘으로 수분제거 후에 감압 농축하여, 얻어진 고체를 헥산으로 씻어준다. 연한 노란색의 고체 화합물 12.7 g (수율 : 82 %) 얻었다. 18 g (43.4 mmol) of the compound 2-d, 0.7 g (13 mmol) of potassium hydroxide and 90 mL of toluene are placed in a 250 mL three-necked round bottom flask and refluxed and stirred for 3 hours. After completion of the reaction, water is added, and the mixture is extracted with methylene chloride. After removing moisture with magnesium sulfate, the mixture was concentrated under reduced pressure, and the resulting solid was washed with hexane. 12.7 g (yield: 82%) of a pale yellow solid compound was obtained.

1H NMR(CDCl3) δ[ppm]: 7.32-7.43(m, 6H), 7.52(d, 1H), 7.58(d, 1H), 7.65-7.69(m, 4H), 7.84(m, 2H), 7.87(d, 1H), 3.11(s, 1H)
1 H NMR (CDCl 3) δ [ppm]: 7.32-7.43 (m, 6H), 7.52 (d, 1H), 7.58 (d, 1H), 7.65-7.69 (m, 4H), 7.84 (m, 2H) , 7.87 (d, 1 H), 3.11 (s, 1 H)

화합물compound 2-f  2-f 의 제조Manufacturing

500 mL-3구 둥근바닥플라스크에 테트라히드로퓨란(THF) 200 mL 와 요오드페닐카바졸 12.6 g(34.1 mmol), 화합물 2-e 14.6 g(41 mmol), 트리에틸아민 13.8 g(136.5 mmol), 디클로로비스트리페닐포스핀팔라듐(II) 0.48 g(0.7 mmol), 요오드화구리 0.1 g(0.7 mmol) 를 넣고 12시간 동안 환류, 교반한다. 반응 종료 후에 감압 여과하고, 얻어진 고체를 헥산으로 재결정하여 흰색의 고체 화합물 7.1 g (수율 : 35 %) 얻었다. (THF), 12.6 g (34.1 mmol) of iodophenylcarbazole, 14.6 g (41 mmol) of the compound 2-e and 13.8 g (136.5 mmol) of triethylamine were added to a 500 mL three- 0.48 g (0.7 mmol) of dichlorobistriphenylphosphine palladium (II) and 0.1 g (0.7 mmol) of copper iodide were added thereto, and the mixture was refluxed for 12 hours and stirred. After completion of the reaction, the mixture was filtered under reduced pressure, and the resulting solid was recrystallized from hexane to obtain 7.1 g (yield: 35%) of a white solid compound.

1H NMR(CDCl3) δ[ppm]: 7.06-7.09(t, 1H), 7.21-7.28(m, 2H), 7.42-7.65(m, 15H), 7.76(d, 1H), 7.81(t, 4H), 7.97-8.01(m, 2H), 8.06(d, 1H), 8.37(s, 2H)
1 H NMR (CDCl 3 )? [Ppm]: 7.06-7.09 (t, 1H), 7.21-7.28 (m, 2H), 7.42-7.65 (m, 15H), 7.76 4H), 7.97-8.01 (m, 2H), 8.06 (d, 1H), 8.37 (s, 2H)

화합물 compound 22 의 제조 Manufacturing

250 mL-3구 둥근바닥플라스크에 화합물 1-g 7 g(18.2 mmol) 과 화합물 2-f 10.8 g(18.2 mmol)을 넣고 디페닐에테르 150 ml 에 녹인다. 4시간 환류 반응 후에 헥산 200 ml 를 투입한다. 형성된 갈색 고체를 감압여과 후 실리카겔 컬럼 (Hexane: EA = 3:1) 으로 분리하여 백색의 고체 화합물 5.1 g(수율 : 70 %) 을 얻었다. Add 7 g (18.2 mmol) of the compound 1-g and 10.8 g (18.2 mmol) of the compound 2-f into a 250 mL three-necked round bottom flask and dissolve in 150 mL of diphenyl ether. After refluxing for 4 hours, 200 ml of hexane is added. The resulting brown solid was filtered off under reduced pressure, and then separated by silica gel column (Hexane: EA = 3: 1) to obtain 5.1 g of a white solid compound (yield: 70%).

1H NMR(CDCl3) δ[ppm]: 6.81(t, 1H), 6.88(t, 1H), 7.17(d, 1H), 7.29(d, 1H), 7.37-7.45(m, 14H), 7.51-7.55(m, 9H), 7.63-7.67(m, 8H), 7.81-7.86(m, 6H), 8.04(t, 2H), 8.10(d, 1H), 8.16(m, 2H), 8.49(d, 1H) 1 H NMR (CDCl 3 )? [Ppm]: 6.81 (t, IH), 6.88 (t, IH), 7.17 (d, IH), 7.29 (d, IH), 7.37-7.45 2H), 8.49 (d, 1H), 8.16 (m, 2H), 8.49 (m, 2H) , 1H)

MALDI-TOF MS: m/z 399.28, cal. 399.75
MALDI-TOF MS: m / z 399.28, cal. 399.75

[실시예 3] 화합물 3의 제조[Example 3] Preparation of Compound 3

Figure 112013029045615-pat00025
Figure 112013029045615-pat00025

화합물compound 3-a  3-a 의 제조Manufacturing

500mL 3구-둥근바닥플라스크에 화합물1-c 10g(24.3mmol) 을 넣고, 비스(피나콜라토)디보론 6.48g(25.5mmol)을 첨가한 후, 1,4-디옥산 200mL 를 넣는다. 1,1'-비스[(디페닐포스피노)페로센]디클로로팔라듐(II),클로로메탄착물 0.36g(0.49mmol)을 첨가하고, 초산칼륨 4.8g (48.6mmol) 을 넣고, 환류하면서 가열교반 한다. 약 12시간 반응 후, 반응물을 상온까지 냉각한다. 염화나트륨 포화수용액과 에틸 아세테이트로 추출한다. 황산마그네슘으로 건조한 후, 활성탄처리 하고, 셀라이트 여과를 한 후, 감압 농축한다. 농축 후 얻어진 고체를 헥산에 현탁한 후, 여과하고 헥산으로 세정하여 노란색의 고체 화합물 9.8 g (수율 : 87.9 %)를 얻었다.10 g (24.3 mmol) of the compound 1-c is placed in a 500 mL three-necked round bottom flask, 6.48 g (25.5 mmol) of bis (pinacolato) diboron are added, and 200 mL of 1,4-dioxane is added. Dichloropalladium (II) and 0.36 g (0.49 mmol) of a chloromethane complex were added, and 4.8 g (48.6 mmol) of potassium acetate was added thereto, followed by heating and stirring with refluxing . After about 12 hours of reaction, the reaction is cooled to room temperature. Extraction is carried out with a saturated aqueous solution of sodium chloride and ethyl acetate. Dried with magnesium sulfate, treated with activated charcoal, filtered through celite, and concentrated under reduced pressure. The solid obtained after concentration was suspended in hexane, followed by filtration and washing with hexane to obtain 9.8 g (Yield: 87.9%) of yellow solid compound.

1H NMR(CDCl3) δ[ppm]: 1.40 (s, 12H) , 7.12(s, 1H), 7.55(m, 7H), 7.68(q, 6H), 8.62(m, 3H)
1 H NMR (CDCl 3 )? [Ppm]: 1.40 (s, 12H), 7.12 (s, 1H), 7.55 (m, 7H), 7.68

화합물compound 3-b  3-b 의 제조Manufacturing

1000mL 3구-둥근바닥플라스크에 17.7 g(38.7 mmol)과 1,4-다이브로모-2,3,5,6-테트라페닐벤젠 19 g(35.2 mmol)을 넣고, 테트라하이드로퓨란(THF) 400 mL 를 가한다. 테트라키스(트리페닐포스핀)팔라듐(0) 0.4 g(0.3 mmol)을 첨가하고, 1M 탄산칼륨 수용액 200 ml 을 넣고 가열 환류한다. 약 18시간 반응 후, 반응물을 상온까지 냉각한다. 염화나트륨 포화수용액 과 디클로로메탄으로 추출하고 황산마그네슘으로 건조한 후, 감압 농축한다. 실리카겔 컬럼 (Hexane: EA = 10:1) 으로 분리하여 농축 후 얻어진 고체를 헥산으로 씻어주면 노란색의 고체 화합물 12.5 g (수율 : 45 %) 을 얻었다.17.7 g (38.7 mmol) of 1,4-dibromo-2,3,5,6-tetraphenylbenzene (19 g, 35.2 mmol) was added to a 1000 mL three-necked round bottom flask and 400 mL Lt; / RTI > 0.4 g (0.3 mmol) of tetrakis (triphenylphosphine) palladium (0) was added, 200 ml of a 1M potassium carbonate aqueous solution was added, and the mixture was heated to reflux. After about 18 hours of reaction, the reaction is cooled to room temperature. The mixture is extracted with saturated aqueous sodium chloride solution and dichloromethane, dried over magnesium sulfate and concentrated under reduced pressure. The solid was separated by silica gel column (Hexane: EA = 10: 1), concentrated and washed with hexane to obtain 12.5 g of a yellow solid compound (yield: 45%).

1H NMR(CDCl3) δ[ppm]: 7.33-7.48(m, 17H), 7.61-7.65(t, 8H), 7.70(d, 2H), 7.76-7.82(m, 6H), 7.94-7.98(m, 2H)
1 H NMR (CDCl 3 )? [Ppm]: 7.33-7.48 (m, 17H), 7.61-7.65 (t, 8H), 7.70 (d, 2H), 7.76-7.82 m, 2H)

화합물compound 3-c  3-c 의 제조Manufacturing

1000mL 3구-둥근바닥플라스크에 요오드페닐카바졸 30 g(81.3 mmol) 을 넣고, 비스(피나콜라토)디보론 22.7 g(89 mmol)을 첨가한 후, 1,4-디옥산 450 mL 를 넣는다. 1,1'-비스[(디페닐포스피노)페로센]디클로로팔라듐(II),클로로메탄착물 1.3 g(1.6 mmol)을 첨가하고, 초산칼륨 15.9 g (162.5 mmol) 을 넣고, 환류하면서 가열교반 한다. 약 12시간 반응 후, 반응물을 상온까지 냉각한다. 염화나트륨 포화수용액과 에틸 아세테이트로 추출한다. 황산마그네슘으로 건조한 후, 감압 농축한다. 농축 후 실리카겔 컬럼 (Hexane: EA = 10:1) 으로 분리하여 얻어진 고체를 메탄올로 재결정하여 흰색의 고체 화합물 19.5 g (수율 : 65 %) 을 얻었다.30 g (81.3 mmol) of iodophenylcarbazole was added to a 1000 mL three-necked round bottom flask, 22.7 g (89 mmol) of bis (pinacolato) diboron were added, and 450 mL of 1,4-dioxane was added . 1.3 g (1.6 mmol) of 1,1'-bis [(diphenylphosphino) ferrocene] dichloropalladium (II) and chloromethane complex were added, and potassium nitrate (15.9 g, 162.5 mmol) was added and the mixture was heated and stirred under reflux . After about 12 hours of reaction, the reaction is cooled to room temperature. Extraction is carried out with a saturated aqueous solution of sodium chloride and ethyl acetate. After drying with magnesium sulfate, the mixture is concentrated under reduced pressure. The concentrate was separated by silica gel column (Hexane: EA = 10: 1) and the obtained solid was recrystallized from methanol to obtain 19.5 g of a white solid compound (yield: 65%).

1H NMR(CDCl3) δ[ppm]: 1.40 (s, 12H) , 7.25-7.33(m, 2H), 7.51-7.58(m, 7H), 7.94-7.98(m, 2H), 8.55(t, 1H)
1 H NMR (CDCl 3) δ [ppm]: 1.40 (s, 12H), 7.25-7.33 (m, 2H), 7.51-7.58 (m, 7H), 7.94-7.98 (m, 2H), 8.55 (t, 1H)

화합물compound 3  3 의 제조Manufacturing

1000mL 3구-둥근바닥플라스크에 화합물 3-b 12 g(15.2 mmol)과 화합물 3-c 6.2 g(16.7 mmol)을 넣고, 테트라하이드로퓨란(THF) 240 mL 를 가한다. 테트라키스(트리페닐포스핀)팔라듐(0) 0.2 g(0.2 mmol)을 첨가하고, 1M 탄산칼륨 수용액 120 ml 을 넣고 가열 환류한다. 약 18시간 반응 후, 반응물을 상온까지 냉각한다. 냉각 후 석출된 고체를 감압 여과한 후 톨루엔에 녹여 셀라이트 여과를 한 후, 감압 농축한다. 농축 후 얻어진 고체를 메탄올로 재결정하여 흰색의 고체 화합물 8.7 g (수율 : 60 %) 을 얻었다. Add 12 g (15.2 mmol) of the compound 3-b and 6.2 g (16.7 mmol) of the compound 3-c into a 1000 mL three-necked round bottom flask, and add 240 mL of tetrahydrofuran (THF). 0.2 g (0.2 mmol) of tetrakis (triphenylphosphine) palladium (0) was added, 120 ml of a 1M potassium carbonate aqueous solution was added, and the mixture was heated to reflux. After about 18 hours of reaction, the reaction is cooled to room temperature. After cooling, the precipitated solid is filtered under reduced pressure, dissolved in toluene, filtered through celite, and concentrated under reduced pressure. The solid obtained after concentration was recrystallized from methanol to obtain 8.7 g (yield: 60%) of a white solid compound.

1H NMR(CDCl3) δ[ppm]: 6.78(t, 1H), 6.91(t, 1H), 7.05(t, 2H), 7.21(t, 2H), 7.32-7.56(m, 24H), 7.66-7.84(m, 14H), 8.21(t, 1H), 8.55(d, 1H), 8.62(d, 1H) 1 H NMR (CDCl 3) δ [ppm]: 6.78 (t, 1H), 6.91 (t, 1H), 7.05 (t, 2H), 7.21 (t, 2H), 7.32-7.56 (m, 24H), 7.66 1H), 8.52 (d, IH), 8.62 (d, IH)

MALDI-TOF MS: m/z 954.16, cal. 954.43
MALDI-TOF MS: m / z 954.16, cal. 954.43

[실시예 4] 화합물 14의 제조[Example 4] Preparation of Compound 14

Figure 112013029045615-pat00026
Figure 112013029045615-pat00026

화합물compound 14-a  14-a 의 제조Manufacturing

500 mL-3구 둥근바닥플라스크에 테트라히드로퓨란(THF) 160 mL 와 2-브로모다이벤조사이오펜 16 g(60.8 mmol), 화합물 2-e 26 g(73 mmol), 트리에틸아민 24.6 g(243.2 mmol), 디클로로비스트리페닐포스핀팔라듐(II) 0.8 g(1.2 mmol), 요오드화구리 0.2 g(1.2 mmol) 를 넣고 12시간 동안 환류, 교반한다. 반응 종료 후에 감압 여과하고, 얻어진 고체를 헥산으로 재결정하여 흰색의 고체 화합물 14.7 g (수율 : 45 %) 얻었다. 160 mL of tetrahydrofuran (THF), 16 g (60.8 mmol) of 2-bromodiforborniophene, 26 g (73 mmol) of 2-e and 24.6 g (243.2 mmol) of triethylamine were added to a 500 mL- 0.8 g (1.2 mmol) of dichlorobistriphenylphosphine palladium (II) and 0.2 g (1.2 mmol) of copper iodide were added to the solution, and the mixture was refluxed for 12 hours and stirred. After completion of the reaction, the mixture was filtered under reduced pressure, and the obtained solid was recrystallized from hexane to obtain 14.7 g of a white solid compound (yield: 45%).

1H NMR(CDCl3) δ[ppm]: 7.26-7.32(m, 2H), 7.43-7.56(m, 7H), 7.61(d, 1H), 7.72(d, 1H), 7.76-7.85(m, 5H), 7.92-7.94(m, 2H), 7.99-8.01(m, 2H), 8.05(d, 1H), 8.15(s, 1H)
1 H NMR (CDCl 3) δ [ppm]: 7.26-7.32 (m, 2H), 7.43-7.56 (m, 7H), 7.61 (d, 1H), 7.72 (d, 1H), 7.76-7.85 (m, 1H), 8.15 (s, 1 H), 8.05 (d, IH), 7.92-7.94

화합물 compound 1414 의 제조 Manufacturing

500 mL-3구 둥근바닥플라스크에 화합물 1-g 14 g(36.4 mmol) 과 화합물 14-a 19.6 g(36.4 mmol)을 넣고 디페닐에테르 250 ml 에 녹인다. 4시간 환류 반응 후에 헥산 200 ml 를 투입한다. 형성된 갈색 고체를 감압여과 후 실리카겔 컬럼 (Hexane: EA = 3:1) 으로 분리하여 백색의 고체 화합물 21.1 g(수율 : 65 %) 을 얻었다. Add 14 g (36.4 mmol) of the compound 1-g and 19.6 g (36.4 mmol) of the compound 14-a to a 500 mL-3-necked round bottom flask and dissolve in 250 mL of diphenyl ether. After refluxing for 4 hours, 200 ml of hexane is added. The formed brown solid was filtered off under reduced pressure, and the residue was separated by silica gel column (Hexane: EA = 3: 1) to obtain 21.1 g of a white solid compound (yield: 65%).

1H NMR(CDCl3) δ[ppm]: 6.84(t, 1H), 6.94-6.98(m, 3H), 7.24-7.27(m, 2H), 7.37-7.72(m, 29H), 7.87-7.88(t, 3H), 8.11(d, 1H), 8.14(s, 1H), 8.87(s, 1H), 8.91(d, 1H) 1 H NMR (CDCl 3) δ [ppm]: 6.84 (t, 1H), 6.94-6.98 (m, 3H), 7.24-7.27 (m, 2H), 7.37-7.72 (m, 29H), 7.87-7.88 ( 1H), 8.91 (d, IH), 8.14 (s, IH)

MALDI-TOF MS: m/z 895.12, cal. 895.75
MALDI-TOF MS: m / z 895.12, cal. 895.75

[실시예 5] 본 발명에 따른 화합물 1을 이용한 유기발광소자의 제작[Example 5] Fabrication of organic light emitting device using Compound 1 according to the present invention

25mm × 75mm × 1.1mm 크기의 유리 기판 상에 막 두께가 750 Å인 인듐 주석 산화물 (ITO)의 투명성 양극을 형성시켰다. 상기 유리 기판을 진공 증착장치에 넣어 약 10-7torr로 감압하였다. 하기 화합물 HIL을 두께가 400Å이 되도록 증착시켜 정공주입층을 형성시켰다. 이어서 하기 화합물 HTL을 두께가 300 Å이 되도록 증착시켜 정공수송층을 형성하였다. 본 발명에 따른 화합물 1을 호스트 재료로, 하기 화합물 Ir(ppy)3을 도판트 재료로 사용하여 7% 중량비로 300 Å 두께가 되도록 증착시켰으며, 하기 화합물 Alq3[트리스(8-히드록시퀴놀린) 알루미늄(Ⅲ)]를 두께가 300 Å이 되도록 증착시켜 발광층을 형성하였다. 상기 발광층 상에 본 발명의 하기 화합물 BCP을 증착시켜 막 두께 300 Å의 전자 수송층으로 성막하였다. 이어, 그 위에 Liq (lithium quinolate)을 증착시켜 전자 주입층을 형성하였다. 이 Liq 막상에 금속 알루미늄을 증착시켜 금속 음극을 형성하여 유기 발광 소자를 제작하였다.A transparent anode of indium tin oxide (ITO) having a film thickness of 750 ANGSTROM was formed on a glass substrate having a size of 25 mm x 75 mm x 1.1 mm. The glass substrate was placed in a vacuum deposition apparatus and reduced in pressure to about 10 -7 torr. The following compound HIL was vapor-deposited to a thickness of 400 ANGSTROM to form a hole injection layer. Subsequently, the following compound HTL was vapor-deposited to a thickness of 300 ANGSTROM to form a hole transport layer. Compound 1 according to the present invention was deposited as a host material to a thickness of 300 Å at a weight ratio of 7% by using Ir (ppy) 3 as a dopant, and the following compound Alq 3 [tris (8-hydroxyquinoline ) Aluminum (III)] was deposited to a thickness of 300 ANGSTROM to form a light emitting layer. The following compound BCP of the present invention was deposited on the light emitting layer to form an electron transport layer having a film thickness of 300 ANGSTROM. Liq (lithium quinolate) was then deposited thereon to form an electron injection layer. Metal aluminum was deposited on the Liq film to form a metal cathode, thereby fabricating an organic light emitting device.

상기와 같이 제작된 유기 발광 전자소자에 0 ~ 15V의 전압을 인가하여 발광시험을 실시하였으며, 하기 표 1에 전기 발광 특성 및 기초 물성 측정 결과를 나타내었다.A voltage of 0 to 15 V was applied to the thus fabricated organic light emitting device, and a luminescence test was performed. Table 1 shows electroluminescence characteristics and basic physical property measurement results.

Figure 112013029045615-pat00027
Figure 112013029045615-pat00027

[실시예 6] 본 발명에 따른 화합물 2를 이용한 유기발광소자의 제작[Example 6] Fabrication of organic light emitting device using compound 2 according to the present invention

상기 실시예 5에서 발광용 재료로서 화합물 1 대신에 화합물 2를 사용한 것을 제외하고는 실시예 5와 동일한 조건 하에서 유기발광소자를 제작하였으며, 하기 표 1에 전기 발광 특성 및 기초 물성 측정 결과를 나타내었다.
An organic light emitting device was fabricated under the same conditions as in Example 5 except that Compound 2 was used instead of Compound 1 as a light emitting material in Example 5. The electroluminescence characteristics and the basic physical property measurement results are shown in Table 1 below .

[실시예 7] 본 발명에 따른 화합물 3을 이용한 유기발광소자의 제작[Example 7] Fabrication of organic light emitting device using Compound 3 according to the present invention

상기 실시예 5에서 발광용 재료로서 화합물 1 대신에 화합물 3을 사용한 것을 제외하고는 실시예 5와 동일한 조건 하에서 유기발광소자를 제작하였으며, 하기 표 1에 전기 발광 특성 및 기초 물성 측정 결과를 나타내었다.
An organic light emitting device was fabricated under the same conditions as those of Example 5 except that Compound 3 was used instead of Compound 1 as a light emitting material in Example 5. The electroluminescence characteristics and basic physical property measurement results are shown in Table 1 below .

[실시예 8] 본 발명에 따른 화합물 4를 이용한 유기발광소자의 제작[Example 8] Fabrication of organic light emitting device using compound 4 according to the present invention

상기 실시예 5에서 발광용 재료로서 화합물 1 대신에 화합물 4를 사용한 것을 제외하고는 실시예 5와 동일한 조건 하에서 유기발광소자를 제작하였으며, 하기 표 1에 전기 발광 특성 및 기초 물성 측정 결과를 나타내었다.
An organic light emitting device was fabricated under the same conditions as in Example 5, except that Compound 4 was used instead of Compound 1 as a light emitting material in Example 5, and the electroluminescence characteristics and basic physical property measurement results are shown in Table 1 below .

[비교예 1] 화합물 CBP를 이용한 유기발광소자의 제작[Comparative Example 1] Fabrication of organic light emitting device using compound CBP

상기 실시예 5에서 발광용 재료로서 화합물 1 대신에 화합물 CBP를 사용한 것을 제외하고는 실시예 5와 동일한 조건 하에서 유기발광소자를 제작하였으며, 하기 표 1에 전기 발광 특성 및 기초 물성 측정 결과를 나타내었다.
An organic light emitting device was fabricated under the same conditions as in Example 5 except that the compound CBP was used in place of the compound 1 as the light emitting material in Example 5. The electroluminescence characteristics and the basic physical property measurement results are shown in Table 1 below .

No.No. 전압(V)Voltage (V) 전류밀도
(mA/cm2)
Current density
(mA / cm 2 )
효율
(cd/A)
efficiency
(cd / A)
색좌표(x,y)The color coordinates (x, y) 휘도
(cd/㎡)
Luminance
(cd / m 2)
실시예 1Example 1 7.007.00 5.395.39 18.9618.96 0.30 , 0.610.30, 0.61 10221022 실시예 2Example 2 7.407.40 2.932.93 36.6736.67 0.29 , 0.620.29, 0.62 10781078 실시예 3Example 3 13.5013.50 3.383.38 30.9330.93 0.31 , 0.610.31, 0.61 10461046 실시예 4Example 4 7.107.10 2.712.71 39.4339.43 0.28 , 0.620.28, 0.62 10721072 비교예 1Comparative Example 1 7.407.40 5.255.25 20.1120.11 0.29 , 0.62 0.29, 0.62 10331033

상기 표 1에 나타난 바와 같이, 본 발명의 피리미딘 유도체를 발광층으로 포함하는 유기발광소자는 종래의 재료 대비 우수한 특성을 보이는 것을 확인할 수 있었다. 즉, 우수한 휘도와 높은 효율을 가질뿐만 아니라 수명특성이 높은 것을 알 수 있다. As shown in Table 1, it was confirmed that the organic light emitting device including the pyrimidine derivative of the present invention as a light emitting layer exhibited superior characteristics to the conventional materials. In other words, it can be seen that not only has excellent luminance and high efficiency, but also high lifetime characteristics.

Claims (9)

하기 화학식 2로 표시되는 피리미딘 유도체를 발광층으로 포함하는 유기발광소자.
[화학식 2]
Figure 112015033295877-pat00049

[상기 화학식 2에서,
R1 내지 R3, R5 및 R6은 서로 독립적으로 (C1-C30)알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이고;
R7은 (C6-C30)아릴이며;
L은 (C6-C30)아릴렌이며;
n은 1 내지 2의 정수이며;
상기 R1 내지 R3, R5 및 R6의 알킬, 아릴 및 헤테로아릴과 R7의 아릴은 (C1-C30)알킬, 할로(C1-C30)알킬, 할로겐, 시아노, (C1-C30)알콕시, (C6-C30)아릴, (C3-C30)헤테로아릴, (C1-C30)알킬이 치환된 (C3-C30)헤테로아릴, 나이트로 및 하이드록시로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있다.]
An organic light emitting device comprising a pyrimidine derivative represented by the following formula (2) as a light emitting layer.
(2)
Figure 112015033295877-pat00049

[In the formula (2)
R 1 to R 3, R 5 and R 6 independently of one another are (C 1 -C 30) alkyl, (C 6 -C 30) aryl or (C 3 -C 30) heteroaryl;
R < 7 > is (C6-C30) aryl;
L is (C6-C30) arylene;
n is an integer of 1 to 2;
Wherein R 1 to R 3, the aryl of R 5 and R 6, aryl and heteroaryl, and R 7 of the (C1-C30) alkyl, halo (C1-C30) alkyl, halogen, cyano, (C1-C30) (C3-C30) heteroaryl, (C3-C30) heteroaryl, (C3-C30) heteroaryl, nitro and hydroxy Can be.]
삭제delete 삭제delete 제 1항에 있어서,
상기 R1 내지 R3, R5 및 R6은 서로 독립적으로 (C1-C30)알킬이거나 하기 구조에서 선택되는 것인 유기발광소자.
Figure 112014104279215-pat00030

[상기 R', R'' 및 R'''는 서로 독립적으로 수소, (C1-C30)알킬, (C6-C30)아릴, (C3-C30)헤테로아릴 또는 (C1-C30)알킬(C6-C30)아릴이다.]
The method according to claim 1,
Wherein R 1 to R 3, R 5 and R 6 are each independently (C 1 -C 30) alkyl or is selected from the following structures.
Figure 112014104279215-pat00030

(C6-C30) aryl, (C3-C30) heteroaryl or (C1-C30) alkyl (C6-C30) heteroaryl, wherein R ', R "and R' C30) aryl.]
제 1항에 있어서,
상기 화학식 2는 하기 화학식 3으로 표시되는 유기발광소자.
[화학식 3]
Figure 112015033295877-pat00031

[상기 화학식 3에서,
R7은 (C6-C30)아릴이며;
L은 (C6-C30)아릴렌이며;
n은 1 내지 2의 정수이며;
R11 또는 R12는 서로 독립적으로 수소, (C1-C30)알킬 또는 (C6-C30)아릴이며;
o는 1 내지 4의 정수이다.]
The method according to claim 1,
(2) is represented by the following formula (3).
(3)
Figure 112015033295877-pat00031

[Formula 3]
R < 7 > is (C6-C30) aryl;
L is (C6-C30) arylene;
n is an integer of 1 to 2;
R 11 or R 12 independently from each other are hydrogen, (C 1 -C 30) alkyl or (C 6 -C 30) aryl;
and o is an integer of 1 to 4.]
제 1항에 있어서,
하기 화합물들로부터 선택되는 것인 유기발광소자.
Figure 112015064261414-pat00032

Figure 112015064261414-pat00033

Figure 112015064261414-pat00034
Figure 112015064261414-pat00035
Figure 112015064261414-pat00036

Figure 112015064261414-pat00037

Figure 112015064261414-pat00038
Figure 112015064261414-pat00039

Figure 112015064261414-pat00051

Figure 112015064261414-pat00043

Figure 112015064261414-pat00044

Figure 112015064261414-pat00045
The method according to claim 1,
Wherein the organic compound is selected from the following compounds.
Figure 112015064261414-pat00032

Figure 112015064261414-pat00033

Figure 112015064261414-pat00034
Figure 112015064261414-pat00035
Figure 112015064261414-pat00036

Figure 112015064261414-pat00037

Figure 112015064261414-pat00038
Figure 112015064261414-pat00039

Figure 112015064261414-pat00051

Figure 112015064261414-pat00043

Figure 112015064261414-pat00044

Figure 112015064261414-pat00045
제 1항에 있어서,
상기 유기발광소자는 제1전극; 제2전극; 및 상기 제1전극과 제2전극 사이에 개재되는 1층 이상의 유기물층으로 이루어져 있으며, 상기 유기물층은 상기 피리미딘 유도체를 함유한 발광층을 포함하는 것인 유기발광소자.
The method according to claim 1,
The organic light emitting device includes a first electrode; A second electrode; And at least one organic material layer interposed between the first electrode and the second electrode, wherein the organic material layer comprises a light emitting layer containing the pyrimidine derivative.
하기 화학식 2로 표시되는 피리미딘 유도체.
[화학식 2]
Figure 112015033295877-pat00050

[상기 화학식 2에서,
R1 내지 R3, R5 및 R6은 서로 독립적으로 (C1-C30)알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이고;
R7은 (C6-C30)아릴이며;
L은 (C6-C30)아릴렌이며;
n은 1 내지 2의 정수이며;
상기 R1 내지 R3, R5 및 R6의 알킬, 아릴 및 헤테로아릴과 R7의 아릴은 (C1-C30)알킬, 할로(C1-C30)알킬, 할로겐, 시아노, (C1-C30)알콕시, (C6-C30)아릴, (C3-C30)헤테로아릴, (C1-C30)알킬이 치환된 (C3-C30)헤테로아릴, 나이트로 및 하이드록시로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있다.]
A pyrimidine derivative represented by the following formula (2).
(2)
Figure 112015033295877-pat00050

[In the formula (2)
R 1 to R 3, R 5 and R 6 independently of one another are (C 1 -C 30) alkyl, (C 6 -C 30) aryl or (C 3 -C 30) heteroaryl;
R < 7 > is (C6-C30) aryl;
L is (C6-C30) arylene;
n is an integer of 1 to 2;
Wherein R 1 to R 3, the aryl of R 5 and R 6, aryl and heteroaryl, and R 7 of the (C1-C30) alkyl, halo (C1-C30) alkyl, halogen, cyano, (C1-C30) (C3-C30) aryl, (C3-C30) heteroaryl, (C3-C30) heteroaryl substituted with (C1-C30) alkyl, nitro and hydroxy Can be.]
삭제delete
KR1020130036327A 2013-04-03 2013-04-03 New pyrimidine derivative and organic light-emitting devices including the same KR101548694B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020130036327A KR101548694B1 (en) 2013-04-03 2013-04-03 New pyrimidine derivative and organic light-emitting devices including the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130036327A KR101548694B1 (en) 2013-04-03 2013-04-03 New pyrimidine derivative and organic light-emitting devices including the same

Publications (2)

Publication Number Publication Date
KR20140120975A KR20140120975A (en) 2014-10-15
KR101548694B1 true KR101548694B1 (en) 2015-09-02

Family

ID=51992637

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020130036327A KR101548694B1 (en) 2013-04-03 2013-04-03 New pyrimidine derivative and organic light-emitting devices including the same

Country Status (1)

Country Link
KR (1) KR101548694B1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101888934B1 (en) * 2015-04-24 2018-08-16 삼성에스디아이 주식회사 Organic compound for optoelectric device andorganic optoelectric device and display device
KR101897041B1 (en) * 2015-05-22 2018-09-10 삼성에스디아이 주식회사 Compound for organic optoelectric device, composition for optoelectric device, organic optoelectric device and display device
KR101940169B1 (en) * 2016-02-04 2019-01-18 삼성에스디아이 주식회사 Organic compound for optoelectric device and organic optoelectric device and display device
EP3312895B1 (en) * 2016-10-24 2021-07-28 Novaled GmbH Organic semiconducting material comprising an electrical n-dopant and an electron transport matrix and electronic device comprising the semiconducting material
TWI756292B (en) * 2016-11-14 2022-03-01 德商麥克專利有限公司 Compounds having an acceptor group and a donor group
US10790455B2 (en) 2017-05-18 2020-09-29 Universal Display Corporation Organic electroluminescent materials and devices
CN108178750A (en) * 2017-12-05 2018-06-19 烟台九目化学制品有限公司 A kind of preparation and its application of benzo [g] quinazoline derivative
KR102530092B1 (en) * 2020-12-14 2023-05-09 솔루스첨단소재 주식회사 Organic light-emitting compound and organic electroluminescent device comprising the same

Also Published As

Publication number Publication date
KR20140120975A (en) 2014-10-15

Similar Documents

Publication Publication Date Title
KR101548694B1 (en) New pyrimidine derivative and organic light-emitting devices including the same
EP2757608B1 (en) Organic electroluminescent element
KR102170951B1 (en) Compound for organic electronic element, organic electronic element using the same, and a electronic device thereof
EP2416397B1 (en) Material for phosphorescent light-emitting element and organic electroluminescent element using same
EP4039774B1 (en) Organic light-emitting material and organic light-emitting element
KR101996651B1 (en) Fluorene derivatives and organic light-emitting diode including the same
KR101707799B1 (en) Organic electroluminescent element
KR101111120B1 (en) Aromatic Compounds and Organic Electroluminescent Devices Using the Same
KR101474713B1 (en) New material for transporting electron and organic electroluminescent device using the same
KR101435462B1 (en) New material for transporting electron and organic electroluminescent device using the same
KR20180112962A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20120009761A (en) Novel organic light emitting compound and organic electroluminescent device comprising same
KR20200091963A (en) Novel compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device
KR20150111106A (en) An organoelectro luminescent compounds and organoelectro luminescent device using the same
KR20120038060A (en) Novel compounds for organic electronic material and organic electroluminescent device using the same
KR20110093055A (en) Novel organic light emitting compound and organic electroluminescent device employing the same
KR20120033017A (en) Novel compounds for organic electronic material and organic electroluminescent device using the same
KR20190020930A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20120020818A (en) Novel compounds for organic electronic material and organic electroluminescent device using the same
KR102166850B1 (en) Novel compound and organic light emitting device comprising the same
KR102092799B1 (en) Organic compound and organic optoelectronic device and display device
CN110520427B (en) Novel heterocyclic compound and organic light-emitting element using same
KR20170131112A (en) Novel 1,2-dihydroindeno[2,1-b]indole compound and organic electroluminescent device comprising the same
CN105461707A (en) Phosphorescent host compound and OELD (Organic Electroluminescent Device) thereof
KR101855308B1 (en) Novel 9H-indeno[2,1-b]pyridine compound and organic electroluminescent device comprising the same

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20130403

PA0201 Request for examination
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20140831

Patent event code: PE09021S01D

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150331

Patent event code: PE09021S01D

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20150629

Patent event code: PE09021S02D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20150731

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20150825

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20150826

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20180822

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20180822

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20200825

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20210624

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20220822

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20240820

Start annual number: 10

End annual number: 10